Correlation between decreased myocardial glucose phosphorylation and the DNA mutation size in myotonic dystrophy

Circulation

Volumn 90, Issue 6, 1994, Pages 2629-2634

  Annane, Djillali ^a,c   Duboc, Denis ^b   Mazoyer, Bernard ^a   Merlet, Pascal ^a   Fiorelli, Marco ^a   Eymard, Bruno ^d   Radvanyi, Hélène ^e   Junien, Claudine ^e   Fardeau, Michel ^d   Gajdos, Philippe ^c   Guerin, François ^b   Syrota, André ^a  

^a DIF   (France)

^b Université Paris ^*  (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e INSERM   (France)

Author keywords

molecular biology; myocardial glucose metabolism; myotonic dystrophy; tomography, positron emission

Indexed keywords

ADULT; ARTICLE; CHROMOSOME 19; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; ELECTROMYOGRAPHY; FEMALE; GENE MUTATION; GLUCOSE METABOLISM; HEART MUSCLE METABOLISM; HUMAN; HUMAN TISSUE; MALE; MYOTONIC DYSTROPHY; PATHOPHYSIOLOGY; PHOSPHORYLATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

EID: 0028658372     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.cir.90.6.2629     Document Type: Article

References (26)

1. Harper P. Myotonic Dystrophy: Major Problems in Neurology. Vol 9, Philadelphia, Pa: WB Saunders Co; 1979.
2. Harley HG, Brook JO, Rundle SA, Crow S, Readon W, Buckler AJ, Harper PS, Housman DE. Expansion of an unstable DNA region and phenotypic variation in myotonic dystrophy. Nature. 1992;355:545-546.
3. Buxton J, Shelbourne P, Davies J, Jones L, Van Tongeren T, Aslanidis C, de Jong P, Jansen G, Anvret H, Riley B, Williamson R, Johnson K. Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy. Nature. 1992;355:547-548.
4. Anonymous. The heart in myotonic dystrophy. Lancet. 1992;339: 528-529. Editorial.
5. Hawley RJ, Milner MR, Gottdiener S, Cohen A. Myotonic heart disease: a clinical follow-up. Neurology. 1991;41:259-262.
6. Grigg LE, Chan W, Mond HG, Vohra JK, Downey WF. Ventricular tachycardia and sudden death in myotonic dystrophy: clinical, electrophysiologic and pathologic features. J Am Coll Cardiol. 1985;6:254-256.
7. Hartwig GB, Rao KR, Radoff FM, Coleman RE, Jones RH, Roses AD. Radionuclide angiocardiographic analysis of myocardial function in myotonic muscular dystrophy. Neurology. 1983;33: 657-660.
8. Nguyen HH, Wolfe JT, Holmes DR, Edwards WD. Pathology of the cardiac conduction system in myotonic dystrophy: a study of 12 cases. J Am Coll Cardiol. 1988;11:662-671.
9. Fiorelli M, Duboc O, Mazoyer BM, Blin J, Eymard B, Fardeau M, Samson Y. Decreased cerebral glucose utilization in myotonic dystrophy. Neurology. 1992;42:91-94.
10. Shipp JC, Opie LH, Challoner D. Fatty acid and glucose metabolism in the perfused heart. Nature. 1961;189:1018-1019.
11. Griggs RC, Wood DS, Working Group on the Molecular Defect in Myotonic Dystrophy. Criteria for establishing the validity of genetic recombination in myotonic dystrophy. Neurology. 1989;39: 420-421.
12. Trebossen R, Mazoyer BM. Count rate performances of TTVO3: the CEA-LETI time-of-flight positron emission tomograph. IEEE Trans Med Imag. 1991;10:261-266.
13. Huesman RH, Mazoyer BM. Kinetic data analysis with a noisy input function. Phys Med Biol. 1987;32:1569-1579.
14. Lammertsma AA, Mazoyer BM. EEC concerted action on cellular degeneration and regeneration studied with PET. Eur J Nucl Med. 1990;16:807-812.
15. 18F-fluoro-2 deoxy-d-glucose studies. J Nucl Med. 1991;32: 733-738.
16. Henry I, Uzan G, Weil D, Nicolas H, Kaplan JC, Marguerie C, Kahn A, Junien C. The genes coding for A-a, B-b, and g chains of fibrinogen map to 4q2. Am J Hum Genet. 1984;36:760-768.
17. Aslanidis C, Jansen G, Amemiya C, Shutler G, Mahadevan M, Tsilfidis C, Chen C, Alleman J, Wormskamp NGM, Vooijs M, Buxton J, Johnson K, Smeetes HJM, Lennon GG, Carrano AV, Korneluk RG, Wieringa B, de Jong PJ. Cloning of the essential myotonic dystrophy region and mapping of the putative defect. Nature. 1992;355:548-551.
18. Brook JD, McCurrach ME, Harley HG, Buckler AJ, Church D, Aburatani H, Hunter K, Stanton VP, Thirion J-P, Hudson T, Sohn R, Zemelman B, Snell RG, Rundle SA, Crow S, Davies J, Shelbourne P, Buxton J, Jones C, Juvonen V, Johnson K, Harper PS, Shaw DJ, Housman DE. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell. 1992;68: 799-808.
19. Mahadevan M, Tsilfidis C, Sabourin L, Shutler G, Amemiya C, Jansen G, Neville C, Narang M, Barcelo J, O'Hoy K, Leblond S, Earle-Macdonald J, de Jong PJ, Wieringa B, Korneluk RG. Myotonic dystrophy mutation: an unstable CTG repeat in the 3′ untranslated region of the gene. Science. 1992;255:1253-1255.
20. Fu YH, Kuhl DPA, Pizzuti A, Fenwick RG Jr, King J, Rajnarayan S, Dunne PW, Dubel J, Nasser GA, Ashizawa T, de Jong P, Wieringa B, Korneluk R, Perryman MB, Epstein HF, Caskey CT. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science. 1992;255:1256-1258.
21. Lavedan C, Hofmann-Radvanyi H, Shelbourne P, Rabès J-P, Duros C, Savoy D, Dehaupas I, Luce S, Johnson K, Junien C. Myotonic dystrophy: size and sex dependent dynamics of CTG meiotic instability, and somatic mosaicism. Am J Hum Genet. 1993; 52:875-883.
22. Schelbert HR. Positron-emission tomography: assessment of myocardial blood flow and metabolism. Circulation. 1985;72(suppl IV):IV-122-IV-133.
23. Moxley RT, Corbett AJ, Minaker KL, Rowe JW. Whole body insulin resistance in myotonic dystrophy. Ann Neurol. 1984;15: 157-162.
24. Roses AD, Appel SH. Phosphorylation of component a of the human erythrocyte membrane in myotonic muscular dystrophy. J Membr Biol. 1975;20:51-58.
25. Thornton CA, Johnson K, Moxley RT. Myotonic dystrophy patients have larger CTG expansions in skeletal muscle than in leukocytes. Ann Neurol. 1994;35:104-107.
26. Shelbourne P, Winquist R, Kunert E, Johnson K. Unstable DNA may be responsible for the incomplete penetrance of the myotonic dystrophy phenotype. Hum Mol Genet. 1992;1:467-473.